Volume : 10, Issue : 12, December – 2023
Title:
OVERVIEW OF RENAL STONES ETIOLOGY, MANAGEMENT, AND PATIENT RECOMMENDATIONS
Authors :
Rasha Khaled Mohammed Sendy, Feras Jamal E. Sendi, Khaled Mohammed Hamed Alghamdi, Tarig Mohamed, Ahmad Saleh Radwan, Hala Ibrahim Alnazawi, Fayez Salem Alenzi, Lama Saeed Abomelha, Rabea Mohammed Madkhali, Abdulelah Ali Alshehry, Suzan Adel A Abualainain, Khaled Abdulrahman Hamdan Alghamdi, Zainab Hassan Almadan, Mohammed Nassar Hasan Al Madani
Abstract :
Background: Renal stones can form in different parts of the urinary system, including the kidneys, ureters, bladder, and urethra. The stones are typically composed of minerals and salts that have crystallized and fused together. Renal stone is often associated with factors such as an imbalance in the substances that make up urine, leading to the precipitation and aggregation of minerals. The stones can vary in size, and their presence in the urinary tract can cause symptoms ranging from mild discomfort to severe pain, depending on the location and size of the stones.
Objective: This review will review the most recent medical literature on renal stone etiology, management, and recommendations.
Methods: Comprehensive research on the renal stone etiology, management, and recommendations. PUBMED and Google Scholar search engines were the databases used for the search process, and articles were collected from 2000 to 2023. The term used in the search were: renal stone, etiology, pathophysiology, management, prevention.
Conclusion: Renal stone, or urolithiasis, involves the formation of stones in the urinary tract, posing a common health issue with multifactorial causes. Mechanisms include a urine biochemical imbalance, leading to supersaturation, nucleation, and crystal aggregation. Presentations range from asymptomatic to painful symptoms. Surgical management prevails, but the rising prevalence poses health and economic challenges. Stone types like calcium oxalate, calcium phosphate, uric acid, struvite, and cystine have distinct etiologies involving metabolic syndrome, genetic factors, and various medical conditions. Diagnosis integrates clinical evaluation and imaging, primarily non-contrast CT scans. Treatments include NSAIDs, surgical interventions, and homeopathic options. Prevention emphasizes lifestyle changes, dietary modifications, and medication use.
Keywords: renal stone, etiology, pathophysiology, management, prevention.
Cite This Article:
Please cite this article in press Rasha Khaled Mohammed Sendy et al Overview Of Renal Stones Etiology, Management, And Patient Recommendations, Indo Am. J. P. Sci, 2023; 10 (12).
Number of Downloads : 10
References:
1. Evan AP: Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatric Nephrology. 2010, 25:831-841. 10.1007/s00467-009-1116-y
2. Ferraro PM, Robertson W, Unwin R: Renal stone disease. Medicine. 2023, 51:229-233. 10.1016/j.mpmed.2023.01.007
3. Kachkoul R, Benjelloun Touimi G, el Mouhri G, El Habbani R, Lahrichi A: Pathophysiological aspects of renal stone formation and stone types. Notulae Scientia Biologicae. 2023, 15:11462. 10.55779/nsb15111462
4. Sakhaee K: Epidemiology and clinical pathophysiology of uric acid kidney stones. Journal of Nephrology. 2014, 27:241-245. 10.1007/s40620-013-0034-z
5. Sakhaee K: Exploring the Role of Inflammation toward the Pathogenesis of Calcium Nephrolithiasis. Clin J Am Soc Nephrol. 2022, 17:338-339. 10.2215/cjn.00510122
6. Szymańska E, Ostaszewska S, Świąder K, Augustynowicz K, Chrzanowski J: Kidney Stones – What should You know? Journal of Education, Health and Sport. 2023, 13:59-64. 10.12775/JEHS.2023.13.05.008
7. Nikhade P, Akulwar A, Surpam S, Vikas MS: Clinical profile of patients with renal stone disease in a tertiary care hospital. International journal of health sciences. 2022, 6:1-8. 10.53730/ijhs.v6nS3.5061
8. Christophe G, Laurence Derain D, Fitsum G-E, et al.: Oxalate : de la physiologie à la pathologie. Néphrologie & Thérapeutique. 2023, 19:201-214. 10.1684/ndt.2023.10
9. Vezzoli G, Scillitani A, Corbetta S, et al.: Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor gene. J Nephrol. 2015, 28:67-72. 10.1007/s40620-014-0106-8
10. Khan SR: Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urological Research. 2012, 40:95-112. 10.1007/s00240-011-0448-9
11. Khamaysi A, Anbtawee-Jomaa S, Fremder M, et al.: Systemic Succinate Homeostasis and Local Succinate Signaling Affect Blood Pressure and Modify Risks for Calcium Oxalate Lithogenesis. Journal of the American Society of Nephrology. 2019, 30.
12. Arafa A, Eshak ES, Iso H: Oxalates, urinary stones and risk of cardiovascular diseases. Medical Hypotheses. 2020, 137:109570. https://doi.org/10.1016/j.mehy.2020.109570
13. Ali A, Tursun H, Talat A, et al.: Association Study of Klotho Gene Polymorphism With Calcium Oxalate Stones in The Uyghur Population of Xinjiang, China. Urology Journal. 2017, 14:2939-2943. 10.22037/uj.v14i1.3636
14. Xu Y, Zeng G, Mai Z, Ou L: Association study of DGKH gene polymorphisms with calcium oxalate stone in Chinese population. Urolithiasis. 2014, 42:379-385. 10.1007/s00240-014-0692-x
15. Huang Y, Zhang Yong H, Chi Ze P, et al.: The Handling of Oxalate in the Body and the Origin of Oxalate in Calcium Oxalate Stones. Urologia Internationalis. 2019, 104:167-176. 10.1159/000504417
16. Kuro-o M: Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression. Current Opinion in Nephrology and Hypertension. 2023, 32.
17. Adnan WAHWM, Nigwekar SU: Calcium Stone: Pathophysiology, Prevention, and Medical Management. Nutritional and Medical Management of Kidney Stones. Han H, Mutter WP, Nasser S (eds): Springer International Publishing, Cham; 2019. 93-106. 10.1007/978-3-030-15534-6_7
18. Vidavsky N, Kunitake JAMR, Estroff LA: Multiple Pathways for Pathological Calcification in the Human Body. Advanced Healthcare Materials. 2021, 10:2001271. https://doi.org/10.1002/adhm.202001271
19. Giovanna P, Monica C, Liliana T, et al.: Understanding the Pathophysiology of Nephrocalcinosis. Updates and Advances in Nephrolithiasis. Layron L (ed): IntechOpen, Rijeka; 2017. Ch. 1. 10.5772/intechopen.69895
20. Peerapen P, Thongboonkerd V: Kidney Stone Prevention. Advances in Nutrition. 2023, 14:555-569. https://doi.org/10.1016/j.advnut.2023.03.002
21. Flannigan R, Choy WH, Chew B, Lange D: Renal struvite stones—pathogenesis, microbiology, and management strategies. Nature Reviews Urology. 2014, 11:333-341. 10.1038/nrurol.2014.99
22. D’Ambrosio V, Capolongo G, Goldfarb D, Gambaro G, Ferraro PM: Cystinuria: an update on pathophysiology, genetics, and clinical management. Pediatric Nephrology. 2022, 37:1705-1711. 10.1007/s00467-021-05342-y
23. Williams JC, Gambaro G, Rodgers A, et al.: Urine and stone analysis for the investigation of the renal stone former: a consensus conference. Urolithiasis. 2021, 49:1-16. 10.1007/s00240-020-01217-3
24. Bilal M, Heerden X, Jansen C, Kelly TP, Wickham B, Molloy MS: Appropriate Imaging Modalities in the Emergency Department for Assessment of Renal Stones. Prehospital and Disaster Medicine. 2023, 38:s155-s156. 10.1017/s1049023x23004053
25. Ragi S, Shah P: Role of Unenhanced Multi-Detector Computed Tomography in Detection of Urinary Calculi in Comparison with Ultrasonography. Biomedical and Pharmacology Journal. 2020, 13:1483-1488.
26. Thia I, Saluja M: An update on management of renal colic. Australian Journal for General Practitioners. 2021, 50:445-449.
27. Qianli M: Simple bed for curing renal stone. 2018.
28. Skolarikos A: Medical treatment of urinary stones. Current Opinion in Urology. 2018, 28.
29. Thomas S, Meena SK, Mishra C: Treatment of urolithiasis with a homoeopathic constitutional remedy: A case report. Journal of Integrated Standardized Homoeopathy. 5. 10.25259/JISH_45_2021
30. Homoeopathy and Renal Stone: An Evidence-Based Clinical Case Report of Non-Surgical Renal Stone Expulsion. Advancements in Homeopathic Research. 2022, 7:49-54. 10.48165/ahr.2022.7.4.5
31. Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. New England Journal of Medicine. 2023, 388:2013-2016. 10.1056/NEJMc2304100
32. Dhayat NA, Bonny O, Roth B, et al.: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. New England Journal of Medicine. 2023, 388:781-791. 10.1056/NEJMoa2209275
33. Singh JK, Singh S, Maha Devan A, Kola A: The various metabolic factors involved in stone recurrence: a prospective study. International Surgery Journal. 2020, 7:393. 10.18203/2349-2902.isj20200285